eSignal IPO Calendar

Week of Expected Pricing	Pending
Company Name	Quark pharmaceuticals Inc.
Proposed Ticker	N/A
CUSIP	N/A
Business Description	A clinical-stage pharmaceutical company engaged in discovering and developing novel RNAi interference or RNAi-based therapeutics.
Lead Underwriter	N/A
Co-Managers	N/A
Initial Shares	N/A
Revised Initial Shares	N/A
Initial Price	N/A
Revised Price	N/A
Final Price	N/A
Final Ticker	N/A